Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with its incidence steadily rising worldwide due to increasing ...

Cervical cancer is one of the most preventable cancers, yet it remains a significant health threat. Here’s why prevention is ...

Completion of SON-1010 (IL12-FHAB) monotherapy dose escalation in Phase 1 SB101 trial; Stable disease (SD) at four months post-initiation of ...

Collaboration to take Cytovation's synthetic peptide, CY-101, into a Phase 2 trial for patients with adrenocortical carcinoma <li /> Ca ...

Immunotherapeutics have transformed cancer outcomes. It is crucial that response patterns seen with them are assessed ...

It would take many years to repopulate all the cell types needed. However ... Stopping smoking has been shown to allow cells that have avoided damage from the cancer-causing chemicals in tobacco smoke ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

This all started at the annual BSP reception for the banking community last month when Philippine Stock Exchange chairman Jose “Titoy” Pardo and Monetary Board member Romeo Bernardo, along with a few ...